The Canadian railroad boosted its full-year outlook, citing firmer freight demand and shifting economic conditions, after posting higher profit and revenue in the second quarter. The deal with ...

Novo Nordisk is pursuing a U.S. court injunction, alleging Eli Lilly's weight-loss drug ads mislead consumers with outdated ...

Sanofi (SNY) and Eli Lilly (LLY)-backed Scribe Therapeutics (SCTX) stock surges nearly 50% after an upsized IPO that raised ...

The legal battle between Novo Nordisk and Eli Lilly is escalating, but analysts are more focused on developments in the lab.

Novo Nordisk's lawsuit seeks a permanent injunction forcing Eli Lilly to pull the ads, as well as a corrective ad campaign.

Eli Lilly just won FDA clearance for an oral GLP-1 that targets over one billion potential patients worldwide, and the stock ...

The Indianapolis based company, Eli Lilly, was originally hoping to get FDA approval this year. Now, it is saying it needs ...

Novo Nordisk has asked a US court to immediately block certain advertisements by rival Eli Lilly for its obesity and diabetes ...

President Trump and pharmaceutical companies are betting big on psychedelics. But hype isn't the same as scientific proof, ...

A 26-year Eli Lilly veteran says the company fired her after she complained of bias and asked for disability accommodations.

Harvest Portfolios Group Inc. (“Harvest”) announces the following distributions for Harvest High Income Shares ETFs™ for the month ending July 31, 2026.

Friday’s preliminary injunction request escalates legal proceedings initiated earlier this week.